WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Insights
Type
People
Practices
Industries
From Date
To Date
Reset Search

Search Results

Client Highlights

5.14.26

Wilson Sonsini Advises Insider One on Acquisition of Bluecore
On May 13, 2026, Insider One, a leading agentic customer engagement platform, announced its acquisition of Bluecore, a leading retail marketing technology platform serving more than 400 U.S. enterprise brands. Terms of the transaction have not been disclosed. Wilson Sonsini Goodrich & Rosati advised Insider One on the transaction.
Client Highlights

12.08.25

Wilson Sonsini Advises Harmonic on $145 Million Acquisition of Video Business Segment by MediaKind
On December 8, 2025, Harmonic, a leader in virtualized broadband and video delivery solutions, announced it has received a binding offer from MediaKind, a leader in cloud-based video streaming technology, to acquire its Video Business segment for approximately $145 million in cash. The transaction, which is expected to close in the first half of 2026, is subject to a French employee works council consultation process and customary closing conditions and regulatory approvals. Wilson Sonsini Goodrich & Rosati is advising Harmonic on the transaction.
Client Highlights

12.03.25

Wilson Sonsini Advises Serent Capital on Recapitalization and Exit from Axiom Medical
On December 3, 2025, Serent Capital, a growth-focused private equity firm, announced the successful recapitalization of Axiom Medical, a leading provider of technology-enabled workplace injury management and employee health solutions. After a seven-year partnership with Serent Capital, Axiom Medical has received a strategic growth investment from NMS Capital to support its next phase of expansion. Wilson Sonsini Goodrich & Rosati advised Serent Capital on the transaction.
  
The Wilson Sonsini team that advised Serent Capital on the transaction included:
 
M&A
Rob Ishii
Catherine Riley Tzipori
David Adler
Elia Perez Villamarin
Yifeng Li
Eric Conner
 
Tax
Jonathan Zhu
Derek Wallace
Han Shen
 
Antitrust and Competition
Ben Labow
Kimberley Biagioli
Julio Albornoz
 
Technology Transactions 
Barath Chari
Morgan Kasenchak
Brittany Von Rueden
Stephanie Stark
 
Employee Benefits and Compensation 
Sriram Krishnamurthy
Matthew Norgard
Madeleine Boshart
Jason Chan
Laura Yun
 
Employment 
Nedim Novakovic
 
Data, Privacy, and Cybersecurity 
Matt Staples
Daniel Chen
Chany Kim
 
Regulatory
Jodi Daniel
Andrea Linna
Nawa Lodin
 
For more information, please see Serent’s news release.
Client Highlights

4.04.25

Wilson Sonsini Advises Skilljar on Acquisition by Gainsight
On April 2, 2025, Gainsight, a world-leading Customer Success platform that helps business drive growth by unifying the post-sales customer journey, acquired Skilljar, a leading Learning Management Software (LMS) provider for external training. Wilson Sonsini Goodrich & Rosati advised Skilljar on the transaction.  

Building on Skilljar’s AI progress, Gainsight is reinforcing its commitment to embarking on an Agentic journey to deliver personalized learning at scale, further underscoring its commitment to driving revenue growth and exceptional customer outcomes. The acquisition also bolsters Gainsight’s established and thriving customer education community by uniting it with Skilljar, creating a leading collective of industry experts to drive this transformative vision.

The Wilson Sonsini team that advised Skilljar on the transaction includes:
Client Highlights

3.25.25

Wilson Sonsini Advises Napster on $207 Million Acquisition by Infinite Reality
On March 25, 2025, Infinite Reality™ (iR), an innovation company powering the next generation of digital media and ecommerce through extended reality, artificial intelligence, and other immersive technologies, announced that the company has entered into a definitive agreement to acquire the iconic online music brand Napster for $207 million. Wilson Sonsini Goodrich & Rosati advised Napster on the transaction.
Client Highlights

1.13.25

Wilson Sonsini Advises Bolt Medical on Merger with Boston Scientific
On January 8, 2025, Boston Scientific announced it has entered into a definitive agreement to acquire Bolt Medical, the developer of an intravascular lithotripsy (IVL) advanced laser-based platform for the treatment of coronary and peripheral artery disease, for up to $900 million. Wilson Sonsini Goodrich & Rosati advised Bolt Medical on the transaction.
Client Highlights

12.20.24

Wilson Sonsini Advises Cohu on Acquisition of Tignis
On December 16, 2024, Cohu, a global supplier of equipment and services optimizing semiconductor manufacturing yield and productivity, announced that it entered into a definitive agreement to acquire Tignis, a provider of artificial intelligence (AI) process control and analytics-based monitoring software. Wilson Sonsini Goodrich & Rosati advised Cohu on the transaction.
Client Highlights

6.18.24

Wilson Sonsini Advises Mobile Health on Acquisition by H.I.G. Growth
On June 17, 2024, H.I.G. Growth Partners (H.I.G. Growth), the dedicated growth capital investment affiliate of H.I.G. Capital, announced the acquisition of Mobile Health Consumer, Inc. (Mobile Health), an end-to-end digital health, wellness, and virtual care SaaS platform. Wilson Sonsini Goodrich & Rosati represented Mobile Health on the transaction.
Client Highlights

2.20.24

Wilson Sonsini Advises Kinnate Biopharma on Acquisition By XOMA
On February 16, 2024, Kinnate Biopharma Inc., a clinical-stage precision oncology company, announced it has entered into a definitive merger agreement whereby XOMA Corporation will acquire Kinnate. Pursuant and subject to the terms of the merger agreement, a wholly owned subsidiary of XOMA will commence a tender offer by March 4, 2024 to acquire all outstanding shares of Kinnate common stock. The merger transaction is expected to close in the first half of 2024. Wilson Sonsini Goodrich & Rosati is advising Kinnate on the transaction.
Client Highlights

12.18.23

Wilson Sonsini Advises OhmConnect on Merger Agreement with Google Nest Renew
On December 14, 2023, Google Nest Renew, a load shifting service for Google Nest thermostats that help customers shift their energy usage to times when the electrical grid is cleaner or energy is less expensive, announced that it is spinning out from Google and combining with OhmConnect, a start-up that Sidewalk Infrastructure Partners (SIP) invests in that helps manage load shifting services for Nest and other smart thermostat brands. The new company will be called "Renew Home." Wilson Sonsini Goodrich & Rosati is advising OhmConnect on the transaction.

SIP will combine their platform company, OhmConnect, with assets from Google Nest’s Renew service business to form Renew Home, which will help customers and energy providers unlock energy savings and rewards in a way that supports a clean energy grid. Renew Home will combine OhmConnect’s innovative home energy management platform, which has helped California avoid dangerous blackouts, with Google Nest’s leadership in energy products and services that help customers prioritize cheaper and cleaner energy. Nest Renew and OhmConnect customers will have improved experiences and offerings, as Renew Home works with partners across the energy industry to offer savings and rewards while accelerating the clean energy transition. SIP is also investing $100 million in fresh capital to drive Renew Home’s future growth as a SIP platform company. The closing of the transaction is subject to regulatory approvals and other customary closing conditions.
Client Highlights

8.03.23

Wilson Sonsini Advises PacBio on Apton Biosystems Acquisition
On August 2, 2023, Pacific Biosciences of California (PacBio), a leading provider of high-quality, long-read sequencing platforms, announced that it has signed a definitive merger agreement to acquire Apton Biosystems, Inc. (Apton), a Bay-Area-based company developing a high throughput short-read sequencer using state-of-the-art optics and image processing, paired with novel clustering and chemistry, that is designed to enable the sequencing of billions of clusters of DNA on one flow cell. Wilson Sonsini Goodrich & Rosati is representing PacBio in the transaction.
Client Highlights

5.09.23

Firm Advises XinThera on Acquisition by Gilead
On May 9, 2023, Gilead Sciences announced the acquisition of San Diego-based XinThera, a privately held biotech company. The acquisition will give Gilead rights to a portfolio of small molecule inhibitors targeting PARP1 for oncology and MK2 for inflammatory diseases that could enter clinical trials later this year. Wilson Sonsini Goodrich & Rosati advised XinThera on the transaction.
  • 1
  • 2
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.